Literature DB >> 22913260

The fundamental link between pneumococcal carriage and disease.

Birgit Simell1, Kari Auranen, Helena Käyhty, David Goldblatt, Ron Dagan, Katherine L O'Brien.   

Abstract

Streptococcus pneumoniae (pneumococcus) is a major cause of worldwide mortality and morbidity, and to a large extent is vaccine-preventable. Nasopharyngeal carriage of pneumococcus precedes disease and is the source of pneumococcal spread between people. The use of vaccine effect on carriage as part of the vaccine licensure and post-vaccine introduction evaluation could facilitate and expand the licensure of new, life-saving pneumococcal vaccines and enable a comprehensive estimate of population effects after vaccine introduction. The authors provide a review of the evidence supporting pneumococcal carriage at the individual level as an immediate and necessary precursor to pneumococcal disease. Based on such a causal link between carriage and disease, the authors emphasize the role of information on pneumococcal carriage in vaccine trials and in public health decision-making.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913260     DOI: 10.1586/erv.12.53

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  241 in total

1.  Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting.

Authors:  Daozhou Gao; Thomas M Lietman; Travis C Porco
Journal:  Math Biosci       Date:  2015-02-26       Impact factor: 2.144

Review 2.  Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial Infection.

Authors:  Bryan van den Broek; Michiel van der Flier; Ronald de Groot; Marien I de Jonge; Jeroen D Langereis
Journal:  J Innate Immun       Date:  2019-07-03       Impact factor: 7.349

3.  Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia.

Authors:  Jennifer A Grousd; Helen E Rich; John F Alcorn
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

5.  Using pneumococcal carriage data to monitor postvaccination changes in invasive disease.

Authors:  Daniel M Weinberger; Dana T Bruden; Lindsay R Grant; Marc Lipsitch; Katherine L O'Brien; Stephen I Pelton; Elisabeth A M Sanders; Daniel R Feikin
Journal:  Am J Epidemiol       Date:  2013-09-07       Impact factor: 4.897

6.  Preventing non bacteremic pneumococcal pneumonia in older adults: historical background and considerations for choosing between PCV13 and PPV23.

Authors:  David S Fedson
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

Review 7.  Prevention of Invasive Pneumococcal Disease: Problems Emerged After Some Years of the 13-Valent Pneumococcal Conjugate Vaccine Use.

Authors:  Nicola Principi; Giuseppe Di Cara; Ilaria Bizzarri; Chiara Isidori; Paola Borgia; Costanza Mignini; Marco Saponara; Alberto Argentiero; Susanna Esposito
Journal:  Curr Infect Dis Rep       Date:  2018-01-24       Impact factor: 3.725

8.  Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.

Authors:  M Nadeem Khan; Qingfu Xu; Michael E Pichichero
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

9.  Longitudinal study on Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonization in HIV-infected and -uninfected infants vaccinated with pneumococcal conjugate vaccine.

Authors:  Shabir A Madhi; Alane Izu; Marta C Nunes; Avye Violari; Mark F Cotton; Patrick Jean-Philippe; Keith P Klugman; Anne von Gottberg; Nadia van Niekerk; Peter V Adrian
Journal:  Vaccine       Date:  2015-04-21       Impact factor: 3.641

10.  Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccine.

Authors:  Nicola Principi; Lorenzo Iughetti; Marco Cappa; Claudio Maffeis; Franco Chiarelli; Gianni Bona; Monia Gambino; Luca Ruggiero; Viviana Patianna; Maria Cristina Matteoli; Marco Marigliano; Paola Cipriano; Silvia Parlamento; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2015-11-17       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.